N-acetyl aspartate concentration in the anterior cingulate cortex in patients with schizophrenia: A study of clinical and neuropsychological correlates and preliminary exploration of cognitive behaviour therapy effects

Psychiatry Research - Neuroimaging

Volumn 182, Issue 3, 2010, Pages 251-260

  Premkumar, Preethi ^a   Parbhakar, Vivek A ^a   Fannon, Dominic ^a   Lythgoe, David ^a   Williams, Steven C ^a   Kuipers, Elizabeth ^a,b   Kumari, Veena ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Chemical shift imaging; Cognitive behaviour therapy; Magnetic resonance spectroscopy; Metabolism; Neuropsychological function; Symptoms

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CHOLINE; CLOZAPINE; CREATINE PHOSPHATE; FLUPENTIXOL; HALOPERIDOL; N ACETYLASPARTIC ACID; OLANZAPINE; RISPERIDONE; ASPARTIC ACID; CREATINE; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; AMINO ACID BRAIN LEVEL; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DSM-IV; FEMALE; FRONTAL LOBE; HUMAN; MALE; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SHORT TERM MEMORY; THERAPY EFFECT; TREATMENT DURATION; WORKING MEMORY; ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; CINGULATE GYRUS; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; FOLLOW UP; METABOLISM; METHODOLOGY; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ASPARTIC ACID; CHILD; CHOLINE; COGNITION DISORDERS; COGNITIVE THERAPY; CREATINE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 77956068844     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2010.02.008     Document Type: Article

References (70)

1. Adler C.M., Malhotra A.K., Elman I., Goldberg T., Egan M., Pickar D., Breier A. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. American Journal of Psychiatry 1999, 156:1646-1649.
2. Andres R.H., Ducray A.D., Schlattner U., Wallimann T., Widmer H.R. Functions and effects of creatine in the central nervous system. Brain Research Bulletin 2008, 76:329-343.
3. Baiano M., David A., Versace A., Churchill R., Balestrieri M., Brambilla P. Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies. Schizophrenia Research 2007, 93:1-12.
4. Bechara A., Damasio A.R., Damasio H., Anderson S.W. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994, 50:7-15.
5. Behrens T.E., Woolrich M.W., Walton M.E., Rushworth M.F. Learning the value of information in an uncertain world. Nature Neuroscience 2007, 10:1214-1221.
6. Bertolino A., Esposito G., Callicott J.H., Mattay V.S., Van Horn J.D., Frank J.A., Berman K.F., Weinberger D.R. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. American Journal of Psychiatry 2000, 157:26-33.
7. Braus D.F., Ende G., Weber-Fahr W., Demirakca T., Henn F.A. Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. Pharmacopsychiatry 2001, 34:251-253.
8. Braus D.F., Ende G., Weber-Fahr W., Demirakca T., Tost H., Henn F.A. Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. European Neuropsychopharmacology 2002, 12:145-152.
9. Burgess P.W., Shallice T. The Hayling and Brixton Tests 1997, Thames Valley Test Company, Bury St Edmunds.
10. Callicott J.H., Bertolino A., Mattay V.S., Langheim F.J., Duyn J., Coppola R., Goldberg T.E., Weinberger D.R. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cerebral Cortex 2000, 10:1078-1092.
11. Carter C.S., van Veen V. Anterior cingulate cortex and conflict detection: an update of theory and data. Cognitive, Affective and Behavioral Neuroscience 2007, 7:367-379.
12. Cornblatt B.A., Risch J.J., Faris G., Friedman D., Erlenmeyer-Kimling L. The Continuous Performance Test, Identical Pairs Version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Research 1988, 26:223-238.
13. Costafreda S.G., Khanna A., Mourao-Miranda J., Fu C.H. Neural correlates of sad faces predict clinical remission to cognitive behavioural therapy in depression. NeuroReport 2009, 20:637-641.
14. Deicken R.F., Zhou L., Schuff N., Weiner M.W. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophrenia Research 1997, 27:65-71.
15. Deicken R.F., Johnson C., Pegues M. Proton magnetic resonance spectroscopy of the human brain in schizophrenia. Reviews in the Neurosciences 2000, 11:147-158.
16. Ende G., Braus D.F., Walter S., Weber-Fahr W., Soher B., Maudsley A.A., Henn F.A. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophrenia Research 2000, 41:389-395.
17. Fannon D., Simmons A., Tennakoon L., O'Ceallaigh S., Sumich A., Doku V., Shew C., Sharma T. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biological Psychiatry 2003, 54:587-598.
18. Ferguson K.J., MacLullich A.M., Marshall I., Deary I.J., Starr J.M., Seckl J.R., Wardlaw J.M. Magnetic resonance spectroscopy and cognitive function in healthy elderly men. Brain 2002, 125:2743-2749.
19. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition (SCID-I/P, 11/2002 revision) 2002, Biometrics Research Department, New York, NY.
20. Fornito A., Yucel M., Dean B., Wood S.J., Pantelis C. Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophrenia Bulletin 2008, 35:973-993.
21. Fowler D., Garety P.A., Kuipers E. Cognitive Behaviour Therapy for Psychosis: Theory and Practice 1995, Wiley, Chichester.
22. Fujimoto T., Takeuch K., Matsumoto T., Kamimura K., Hamada R., Nakamura K., Kato N. Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia. Psychiatry Research 2007, 154:49-58.
23. Goff D.C., Hennen J., Lyoo I.K., Tsai G., Wald L.L., Evins A.E., Yurgelun-Todd D.A., Renshaw P.F. Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biological Psychiatry 2002, 51:493-497.
24. Gold J.M., Carpenter C., Randolph C., Goldberg T.E., Weinberger D.R. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Archives of General Psychiatry 1997, 54:159-165.
25. Heaton R.K., Chelune G.J., Tally J.L., Kay G.G., Curtiss G. Wisconsin Card Sorting Test Manual: Revised and Expanded 1993, Psychological Assessment Resources, Odessa, FL.
26. Honea R., Crow T.J., Passingham D., Mackay C.E. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. American Journal of Psychiatry 2005, 162:2233-2245.
27. Hughes C., Kumari V., Soni W., Das M., Binneman B., Drozd S., O'Neil S., Mathew V., Sharma T. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophrenia Research 2003, 59:137-146.
28. Jung R.E., Brooks W.M., Yeo R.A., Chiulli S.J., Weers D.C., Sibbitt W.L. Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain. Proceedings. Biological Sciences 1999, 266:1375-1379.
29. Kaneda M., Osaka N. Role of anterior cingulate cortex during semantic coding in verbal working memory. Neuroscience Letters 2008, 436:57-61.
30. Kay S.R., Fiszbein A., Opier L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
31. Kennerley S.W., Dahmubed A.F., Lara A.H., Wallis J.D. Neurons in the frontal lobe encode the value of multiple decision variables. Journal of Cognitive Neuroscience 2008, 21:1162-1178.
32. Kim J., Whyte J., Wang J., Rao H., Tang K.Z., Detre J.A. Continuous ASL perfusion fMRI investigation of higher cognition: quantification of tonic CBF changes during sustained attention and working memory tasks. Neuroimage 2006, 31:376-385.
33. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry 1994, 51:199-214.
34. Kumari V., Peters E.R., Fannon D., Antonova E., Premkumar P., Anilkumar A.P., Williams S.C., Kuipers E.A. Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive behaviour therapy in schizophrenia. Biological Psychiatry 2009, 66:594-602.
35. Lahti A.C., Koffel B., LaPorte D., Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 1995, 13:9-19.
36. Lenartowicz A., McIntosh A.R. The role of anterior cingulate cortex in working memory is shaped by functional connectivity. Journal of Cognitive Neuroscience 2005, 17:1026-1042.
37. Malhotra A.K., Pinals D.A., Adler C.M., Elman I., Clifton A., Pickar D., Breier A. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 1997, 17:141-150.
38. McLean M.A., Woermann F.G., Barker G.J., Duncan J.S. Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magnetic Resonance in Medicine 2000, 44:401-411.
39. McMorris T., Harris R.C., Swain J., Corbett J., Collard K., Dyson R.J., Dye L., Hodgson C., Draper N. Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology (Berl) 2006, 185:93-103.
40. McMorris T., Harris R.C., Howard A.N., Langridge G., Hall B., Corbett J., Dicks M., Hodgson C. Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior. Physiology and Behaviour 2007, 90:21-28.
41. Miller B.L. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR in Biomedicine 1991, 4:47-52.
42. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003, 40:881-884.
43. Ohrmann P., Siegmund A., Suslow T., Pedersen A., Spitzberg K., Kersting A., Rothermundt M., Arolt V., Heindel W., Pfleiderer B. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. Journal of Psychiatric Research 2007, 41:625-634.
44. Ohrmann P., Kugel H., Bauer J., Siegmund A., Kolkebeck K., Suslow T., Wiedl K.H., Rothermundt M., Arolt V., Pedersen A. Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy. Schizophrenia Research 2008, 106:156-163.
45. Ongur D., Prescot A.P., Jensen J.E., Cohen B.M., Renshaw P.F. Creatine abnormalities in schizophrenia and bipolar disorder. Psychiatry Research: Neuroimaging 2009, 172:44-48.
46. Osaka N., Osaka M., Kondo H., Morishita M., Fukuyama H., Shibasaki H. The neural basis of executive function in working memory: an fMRI study based on individual differences. Neuroimage 2004, 21:623-631.
47. Perry G., Nunomura A., Hirai K., Zhu X., Perez M., Avila J., Castellani R.J., Atwood C.S., Aliev G., Sayre L.M., Takeda A., Smith M.A. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?. Free Radical Biology and Medicine 2002, 33:1475-1479.
48. Peterson B.S., Skudlarski P., Gatenby J.C., Zhang H., Anderson A.W., Gore J.C. An fMRI study of Stroop word-color interference: evidence for cingulate subregions subserving multiple distributed attentional systems. Biological Psychiatry 1999, 45:1237-1258.
49. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 1993, 30:672-679.
50. Rae C., Digney A.L., McEwan S.R., Bates T.C. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. Proceedings. Biological Sciences 2003, 270:2147-2150.
51. Ross A.J., Sachdev P.S. Magnetic resonance spectroscopy in cognitive research. Brain Research. Brain Research Reviews 2004, 44:83-102.
52. Rushworth M.F., Walton M.E., Kennerley S.W., Bannerman D.M. Action sets and decisions in the medial frontal cortex. Trends in Cogntive Sciences 2004, 8:410-417.
53. Rutten B.P., Korr H., Steinbusch H.W., Schmitz C. The aging brain: less neurons could be better. Mechanisms of Ageing and Development 2003, 124:349-355.
54. Sanches R.F., Crippa J.A., Hallak J.E., de Sousa J.P., Araujo D., Santos A.C., Zuardi A.W. Proton magnetic resonance spectroscopy of the frontal, cingulate and perirolandic cortices and its relationship to skin conductance in patients with schizophrenia. Brazilian Journal of Medical and Biological Research 2008, 41:1132-1141.
55. Schlosser R.G., Koch K., Wagner G., Nenadic I., Roebel M., Schachtzabel C., Axer M., Schultz C., Reichenbach J.R., Sauer H. Inefficient executive cognitive control in schizophrenia is preceded by altered functional activation during information encoding: an fMRI study. Neuropsychologia 2008, 46:336-347.
56. Shapiro A.M., Benedict R.H., Schretlen D., Brandt J. Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. The Clinical Neuropsychologist 1999, 13:348-358.
57. Smith E.E., Jonides J. Storage and executive processes in the frontal lobes. Science 1999, 283:1657-1661.
58. Szoke A., Trandafir A., Dupont M.E., Meary A., Schurhoff F., Leboyer M. Longitudinal studies of cognition in schizophrenia: meta-analysis. British Journal of Psychiatry 2008, 192:248-257.
59. Tayoshi S., Sumitani S., Taniguchi K., Shibuya-Tayoshi S., Numata S., Iga J.I., Nakataki M., Ueno S.I., Harada M., Ohmori T. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy ((1)H-MRS). Schizophrenia Research 2009, 108:69-77.
60. Theberge J., Bartha R., Drost D.J., Menon R.S., Malla A., Takhar J., Neufeld R.W., Rogers J., Pavlosky W., Schaefer B., Densmore M., Al-Semaan Y., Williamson P.C. Glutamate and glutamine measured with 4.0T proton MRS in never-treated patients with schizophrenia and healthy volunteers. American Journal of Psychiatry 2002, 159:1944-1946.
61. Theberge J., Al-Semaan Y., Williamson P.C., Menon R.S., Neufeld R.W., Rajakumar N., Schaefer B., Densmore M., Drost D.J. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. American Journal of Psychiatry 2003, 160:2231-2233.
62. Theberge J., Al-Semaan Y., Drost D.J., Malla A.K., Neufeld R.W., Bartha R., Manchanda R., Menon R., Densmore M., Schaefer B., Williamson P.C. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla. Psychiatry Research 2004, 131:107-114.
63. Tranberg M., Stridh M.H., Guy Y., Jilderos B., Wigstrom H., Weber S.G., Sandberg M. NMDA-receptor mediated efflux of N-acetylaspartate: physiological and/or pathological importance?. Neurochemistry International 2004, 45:1195-1204.
64. Tranberg M., Abbas A.K., Sandberg M. In vitro studies on the putative function of N-acetylaspartate as an osmoregulator. Neurochemical Research 2007, 32:1248-1255.
65. Walton M.E., Croxson P.L., Behrens T.E., Kennerley S.W., Rushworth M.F. Adaptive decision making and value in the anterior cingulate cortex. Neuroimage 2007, 36(Suppl 2):T142-T154.
66. Wechsler D. Wechsler Memory Scale-Revised 1987, Psychological Corporation, New York.
67. Weinberger D.R., Aloia M.S., Goldberg T.E., Berman K.F. The frontal lobes and schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences 1994, 6:419-427.
68. Wood S.J., Yucel M., Wellard R.M., Harrison B.J., Clarke K., Fornito A., Velakoulis D., Pantelis C. Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: a proton magnetic resonance spectroscopy study at 3T. Schizophrenia Research 2007, 94:328-331.
69. Yamasue H., Fukui T., Fukuda R., Yamada H., Yamasaki S., Kuroki N., Abe O., Kasai K., Tsujii K., Iwanami A., Aoki S., Ohtomo K., Kato N., Kato T. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. NeuroReport 2002, 13:2133-2137.
70. Yeo R.A., Hill D., Campbell R., Vigil J., Brooks W.M. Developmental instability and working memory ability in children: a magnetic resonance spectroscopy investigation. Developmental Neuropsychology 2000, 17:143-159.